Abstract: In a model of hemorrhagic shock, end-tidal carbon dioxide tension (EtCO 2 ) has been shown to reflect the dependence of oxygen delivery (DO 2 ) and oxygen consumption (VO 2 ) at the onset of shock. The objectives of the present study were to determine whether variations in EtCO 2 during volume expansion (VE) are correlated with changes in oxygen extraction (O 2 ER) and whether EtCO 2 has predictive value in this respect.
INTRODUCTION
T he objective of volume-based hemodynamic resuscitation is to raise cardiac output (CO) and increase or restore the delivery of oxygen (DO 2 ) required to meet the demands of oxygen consumption (VO 2 ). 1 If DO 2 drops below a critical threshold, oxygen extraction (O 2 ER) cannot increase in proportion to demand, and VO 2 becomes dependent on DO 2 . Before critical O 2 ER values arise, DO 2 can decrease independently of VO 2 (because DO 2 exceeds VO 2 ) and O 2 ER will increase with demand (as demonstrated by a progressive fall in central venous saturation [ScvO 2 ]). 2 When O 2 ER cannot rise any further, VO 2 decreases and the body's metabolism becomes partially anaerobic (with a resulting increase in blood lactate levels). 3 In many pathological situations, VO 2 remains constant over a wide range of DO 2 values as a result of adjustments in tissue oxygen uptake. 4 ScvO 2 is a clinically meaningful measure of tissue oxygenation, 5 since it assesses the adequacy of DO 2 with regard to VO 2 . 6 Several studies have shown that ScvO 2 -based hemodynamic resuscitation is associated with lower morbidity and mortality rates during anesthesia and intensive care. 7, 8 Exhaled CO 2 (end-tidal carbon dioxide tension, EtCO 2 ) is also monitored in patients in the intensive care unit (ICU) or during anesthesia. 9 Over short periods (and assuming a constant metabolic state), there is a qualitative relationship between EtCO 2 and CO. 10, 11 Thus, EtCO 2 can be used as a noninvasive, continuous measure of CO during several clinical situations with low-flow states. [10] [11] [12] [13] These results have not been confirmed in patients scheduled for surgery, in whom CO increased upon volume expansion (VE).
14 One possible explanation is that patients scheduled for surgery and patients in the ICU differ in terms of systemic oxygen supply dependency. Most of the literature studies were performed in low-flow states, in which patients have been on a dependence phase between DO 2 and VO 2 . This is probably not the case for most patients in the operating theatre. Based on a model of hemorrhagic shock in dogs, Guzman et al 12 demonstrated that EtCO 2 can reflect the dependence of DO 2 and VO 2 at the onset of shock and during hemodynamic resuscitation. Thereafter, Dubin et al 13 
METHODS

Ethics
The study's objectives and procedures were approved by the local independent ethics committee. Ethical approval for this study (Ethical Committee No. RNI2014-15) was provided by the Comité de Protection des Personnes Nord-Ouest II CHU-Place V. Pauchet, 80054 AMIENS Cedex 1 (Chairperson Bourgueil Thierry) on June 26, 2014. All patients received written information on the study and gave their verbal consent to participation prior to surgery. The present manuscript was drafted in compliance with the STROBE checklist for cohort studies. 15 
Patients
This prospective, observational study started on June 30, 2014 at Amiens University Hospital's cardio vascular and thoracic ICU over a 6-month period. The inclusion criteria were any major patient over 18 years, ventilated with controlled positive ventilation, for whom the physician decided to do a VE within hours of admission to the ICU. The indications for VE were arterial hypotension (systolic arterial pressure [SAP] lower than 90 mm Hg and/or mean arterial pressure [MAP] lower than 65 mm Hg), oliguria (urine output lower than 0.5 mL/kg per h over 1 h), clinical signs of hypoperfusion (skin mottling, capillary refill time over 2 s), and arterial hyperlactatemia (arterial lactate over 2 mmol/L). The noninclusion criteria were permanent arrhythmia, chronic obstructive pulmonary disease, and acute lung injury. The exclusion criteria were spontaneous ventilation, poor echogenicity, and arrhythmia.
Hemodynamic Parameters
An internal jugular vein central venous catheter and an arterial catheter were placed in all patients. Central venous pressure (CVP) and blood pressure were measured with a transducer zeroed at the mid-axillary line. Transthoracic echocardiography (Cx50, Philips Medical System, Suresnes, France) was performed by a physician who was blinded to the study outcomes. The left ventricular ejection fraction was measured using Simpson biplane method with a 4-chamber view. The diameter of the left ventricular outflow tract (LVOT) was measured on a long-axis parasternal view upon patient inclusion. Aortic area (SAo, in cm 2 ) was calculated as p Â LVOT 2 /4. The aortic velocity-time integral (VTIAo) was measured with pulsed Doppler and a 5-chamber apical view. Stroke volume (SV) (mL) was calculated as VTIAo Â SAo. CO (in L/min) was calculated as SV Â heart rate (HR). Mean echocardiographic parameters were calculated from 5 measurements (regardless of the respiratory cycle) and analyzed retrospectively. The intra and inter reproducibility of VTIAo measurements was tested prior to the study. Reproducibility values were 4.4 AE 3.9% and 4.4 AE 3.2%, respectively.
Oxygenation Parameters and EtCO 2
We recorded the ventilator settings (tidal volume, plateau pressure, and end-expiratory pressure) at baseline. Exhaled CO 2 was continuously measured at the tip of the endotracheal tube using a CO 2 cuvette with an integrated sensor (Drager, Luebeck, Germany). All parameters were measured on arterial and central venous blood gases. Arterial and venous blood gas levels, the lactate level, the blood hemoglobin concentration, and oxyhemoglobin saturation were assayed using an automated analyzer (ABL800 FLEX, Radiometer, Bronshoj, Denmark 16 The alveolar dead space (Vd/Vt) was estimated from EtCO 2 and PaCO 2 as (PaCO 2 À EtCO 2 )/PaCO 2 .
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Study Procedures
The following clinical parameters were recorded: age, gender, weight, and main diagnosis. First, a passive leg-raising (PLR) test was performed in order to evaluate the effects on SV, and assess preload status. After an equilibration period, baseline measurements of HR, SAP, MAP, diastolic arterial pressure (DAP), CVP, SV, CO, EtCO 2 , and arterial/venous blood gas levels were obtained. In the present study, VE always consisted in infusing 500 mL of lactated Ringer solution over 10 min; 10 min after VE, a second set of measurements (SAP, MAP, DAP, HR, CVP, SV, CO, EtCO 2 , and arterial/venous blood gas levels) was recorded. All patients had been sedated via the continuous infusion of propofol and were fully accustomed to mechanical ventilation. All patients underwent mechanical ventilation in volume-controlled mode with a tidal volume set to 7 to 9 mL/kg of ideal body weight, and a positive endexpiratory pressure of 5 to 8 cm H 2 O. Ventilator settings (oxygen inspired fraction, tidal volume, respiratory rate, and end positive pressure) and norepinephrine dosage were not modified during the study period.
Statistical Analysis
We calculated that a sample of 50 patients would be sufficient to demonstrate a correlation of over 0.7 between EtCO 2 , ERO 2 , VO 2 , DO 2 , and CO. Fifty-five patients were therefore recruited, taking into account the exclusion criteria. The variables' distribution was assessed using a KolmogorovSmirnov test. Data are expressed as the proportion (in %), the mean (standard deviation, SD) or the median (interquartile range), as appropriate. We measured the magnitude of EtCO 2 variations during VE by calculating the effect size (the mean divided by the SD). 18, 19 The effect size was 0.74. Then, we calculated the coefficient of variation (CV), precision and least significant change (LSC) for EtCO 2 . LSC is the least amount of EtCO 2 change that can be considered statistically significant; that is, the minimum percentage change between successive measurements that can be considered not due to random error and therefore representing a real change in ETCO 2 . The EtCO 2 CV and LSC were determined in all studied patients at baseline during stable respiratory and hemodynamic conditions. The CV (95% confidence interval [CI]) was 1.8% (0.9-2.7) and the LSC (95% CI) was 2.5% (1.3-3.8). EtCO 2 responder was defined as an increase of EtCO 2 of more than 4% in EtCO 2 after VE. EtCO 2 nonresponder was defined as an increase of EtCO 2 of <4% in EtCO 2 after VE. This cut off correspond to LSC with its 95% CI. 20 Fluid responder was defined as an increase of more than 15% in the SV during VE. 21 Fluid nonresponder was defined as an increase of <15% in the SV during VE. The nonparametric Wilcoxon rank sum test, Student paired t test, Student t test, and the Mann-Whitney test were used to assess statistical significance, as appropriate. Linear correlations were tested using Pearson or Spearman rank method. A receiveroperating characteristic curve was established for EtCO 2 , with a view to predicting a decrease of over 10% in O 2 ER, and a increase over 10% in ScVO 2 . 22 The threshold for statistical significance was set to P < 0.05. SPSS software (version 21, IBM, New York, NY) was used to perform statistical analysis.
RESULTS
Fifty-one postoperative patients were analyzed after inclusion in the study ( Figure 1 , Table 1 ). The indications for VE were as follows: arterial hypotension (n ¼ 34), oliguria (n ¼ 4), and clinical signs of hypoperfusion (n ¼ 13). Eighteen (35%) patients had hyperlactatemia. Indications for VE did not differ between EtCO 2 responders and EtCO 2 nonresponders (P > 0.05). Twenty (39%) of the 51 patients were classified as EtCO 2 responders. All EtCO 2 responders were also fluid responders and displayed a mean (95% CI) EtCO 2 of 7% (6-9) during VE ( Figure 1) . Thirty-one patients were classified as EtCO 2 nonresponders and displayed a mean (95% CI) change in EtCO 2 of 0% (À1 to 1) during VE (Figure 1 ). Twenty-six of the EtCO 2 nonresponders were fluid responders and 5 were fluid nonresponders. At baseline, prevalence of norepinephrine treatment did not differ between the 2 groups of patients (12 [39%] EtCO 2 nonresponders vs 7 [35%] EtCO 2 responders, P ¼ 0.1). At baseline, SV variations with PLR did not differ between EtCO 2 responders and EtCO 2 nonresponders (P > 0.05, Table 2 ).
Effect of VE on Hemodynamic and Blood Gas Parameters
In the study population as a whole, VE led to increases in MAP, CVP, SV, CO, EtCO 2 , DO 2 , PvO 2 , and ScvO 2 , and decreases in HR, PvCO 2 , O 2 ER, and alveolar dead space (Tables 2 and 3 ). At baseline, MAP, PvO 2 , and ScvO 2 were lower and VO 2 (Table 4) . A change of more than 4% in EtCO 2 during VE predicted a decrease of more than 10% in the VO 2 /DO 2 ratio with an area under the curve (95% CI) of 0.88 (0.77-0.96) (P < 0.0001), a sensitivity of 71% (53-85), a specificity of 94% (71-100), a positive likelihood ratio of 12, negative likelihood ratio of 0.31, a positive predictive value of 96, and a negative predictive value of 62. In the same way, change in EtCO 2 during VE predicted an increase of more than 10% in ScVO 2 with an area under the curve (95% CI) of 0.90 (0.78-0.97), P < 0.0001.
DISCUSSION
Our results demonstrated that during VE, the occurrence of concomitant increases in EtCO 2 and CO depends on the relationship between VO 2 and DO 2 ; an increase in CO was not necessarily accompanied by an increase in EtCO 2 . Only patients with a high extraction ratio (i.e., low ScvO 2 values) will display an increase in EtCO 2 . Thus, changes in EtCO 2 during VE reflect changes in O 2 ER in response to a rise in DO 2 . Hence, during VE, EtCO 2 may be a useful noninvasive indicator of changes in systemic oxygen supply dependency when fixed ventilation is maintained.
Several preclinical and clinical studies have demonstrated that EtCO 2 can be used as a noninvasive, continuous measure of CO during low-flow states (cardiac arrest, hemorrhagic shock, cardiopulmonary resuscitation, circulatory shock, etc.). [9] [10] [11] Similarly, EtCO 2 has been shown to reflect changes in VO 2 and VCO 2 during hemorrhagic shock. 12, 13 Our present results demonstrated that EtCO 2 may reflect changes in systemic oxygen supply associated with changes in CO during VE in nonseptic patients. All the patients in our study were postoperative sedated and nonhypothermic. Alveolar ventilation procedures and norepinephrine dosage did not change over the study period, and CO increased during VE. Even then, only 50% of fluid responders displayed an increase in EtCO 2 , thus EtCO 2 was poorly correlated with changes in CO. Our results confirm previous findings in the operating theatre, where EtCO 2 and CO were rather low.
14 To determine the mechanisms by which increase in CO increase EtCO 2 during VE, 1 would have to consider the study population and the effects of increase CO on blood gas parameters.
At baseline, EtCO 2 responders had a lower MAP than EtCO 2 nonresponders, whereas the 2 groups did not differ significantly in terms of preload status (i.e., variations in SV during PLR) and CO. Although EtCO 2 responders and EtCO 2 nonresponders did not differ in terms of DO 2 , the EtCO 2 responders had a higher VO 2 and thus a higher O 2 ER and lower ScVO 2 . VE led to an increase in CO (and thus DO 2 ) and a decrease in PvCO 2 in fluid responders. Nevertheless, VE in EtCO 2 responders led to a recovery of DO 2 in consistent with oxygen needs: the decrease in O 2 ER resulted in an increase in PvO 2 and ScvO 2 . In contrast, EtCO 2 nonresponsiveness was associated with an increase in DO 2 and VO 2 because baseline Values are expressed as the mean (standard deviation) or the median (interquartile range).
CO ¼ cardiac output, CVP ¼ central venous pressure, DO 2 ¼ oxygen delivery, EtCO 2 ¼ end-tidal carbon dioxide pressure, HR ¼ heart rate, MAP ¼ mean arterial pressure, O 2 ER ¼ oxygen extraction, PLR ¼ passive leg raising, SV ¼ stroke volume, VE ¼ volume expansion, VO 2 ¼ oxygen consumption.
Ã P < 0.05 within groups (between baseline and VE). 
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O 2 ER did not rise. Thus, concomitant increases in EtCO 2 and CO may result from several different mechanisms. Under steady-state conditions, alveolar CO 2 elimination and therefore EtCO 2 depend on several factors: CO 2 production (VCO 2 , due to metabolism), alveolar ventilation (mechanical ventilation), pulmonary perfusion (CO), and V/Q matching. VCO 2 depends on pulmonary elimination and metabolic production of CO 2 . The changes in EtCO 2 in our population could not be explained by metabolic production of CO 2 for several reasons. In a model of hemorrhagic shock, Dubin et al 13 demonstrated that VCO 2 could decrease EtCO 2 during the period of VO 2 supply dependency at low CO. The alterations in VCO 2 were statistically significant for changes in CO, DO 2 , and VO 2 values that were greater than those observed in our study. A further mechanism might be related to removal of peripheral tissue CO 2 produced under anaerobic conditions. 23 In the present study, the baseline O 2 ER values were below critical literature values at which tissue hypoxia was associated with anaerobic metabolism. 24 Moreover, no inter and intra group difference was shown for CaCO 2 and CvCO 2 . One can hypothesize that decrease (increases) in O 2 ER (ScVO 2 ) and CO will decrease the venous blood's capacity to carry CO 2 at a given PvO 2 , which in turn will offset the increase in CO 2 delivery when CO rises. 25 Thus, an increase in DO 2 may decrease PvCO 2 and increase CO 2 delivery to the lung. At the same time, alveolar Vd/Vt fell in EtCO 2 responders (despite constant minute ventilation) as a result of 2 mechanisms. The increases in PvO 2 and CO may have improved alveolar perfusion pressure and the ventilation-perfusion ratio of the lung, which would tend to decrease PaCO 2 . 26, 27 In our population, changes in EtCO 2 had good correlation with changes in PvO 2 and ScVO 2 whereas they were not associated to those in PaCO 2 or PvCO 2 . These mechanisms may explain (at least in part) why EtCO 2 did not change in EtCO 2 nonresponders, whereas CO did.
In summary, EtCO 2 responders had a low DO 2 with regard to their VO 2 resulting in higher O 2 ER (lower ScVO 2 ). VE restored the relationship between VO 2 /DO 2 through CO changes and increasing PvO 2 and CO 2 delivery to the lung, which improved the patients' ventilation-perfusion ratio and thus increased EtCO 2 .
The present study had a number of limitations. The study population (patients after heart surgery) may have differed from septic shock patients. Most of our patients suffered from acute circulatory failure as a result of perioperative hypovolemia, whereas septic patients generally have acute circulatory failure that combines hypovolemia, changes in microvascular perfusion and cellular dysoxia. A patient's response to VE, the relationship between DO 2 and VO 2 , and the extent of anaerobic metabolism may depend on the etiology of acute circulatory failure. 28 -30 We measured blood gas parameters from a central venous catheter and not from a pulmonary artery catheter. Although ScVO 2 cannot give a precise absolute estimate of SvO 2 , it can serve as a guide to changes in SvO 2 and VO 2 .
30,31
Monnet et al used blood gas parameters from a central venous catheter to assess VO 2 , DO 2 , and their changes over time during fluid expansion in septic patients. 31 In our study, changes in ScVO 2 (measured) and O 2 ER (calculated) had good correlation (r ¼ À0.89, P < 0.0001). Moreover, predictive values of EtCO 2 changes during VE did not differ to predict an increase of ScVO 2 or a decrease of VO 2 /DO 2 ratio. Since we performed repeated measurements of blood gas levels, mathematical coupling cannot be ruled out. But De Backer et al demonstrated that during controlled conditions, VO 2 calculated from hemodynamic data is a valid alternative to VO 2 derived from respiratory gas measurements. 30, 32 The method used to calculate alveolar dead space was not standardized and may have introduced bias into the determination. The difference between EtCO 2 and PaCO 2 is altered in patients with altered ventilation/ perfusion ratios (due to atelectasis, chronic heart failure, acute respiratory distress syndrome, etc.). In the present study, patients with chronic pulmonary disease or acute lung injury were excluded to limit this bias. Furthermore, these results cannot be extrapolated to EtCO 2 changes that result from the administration of vasopressor drugs. 33 EtCO 2 changes seem small but they are similar to those used to predict fluid responsiveness. 34 Lastly, given that we did not measure VCO 2 , we cannot rule out the occurrence of changes in metabolic production of CO 2 during the VE-induced increase in CO.
CONCLUSIONS
During VE, an increase in CO was not necessarily accompanied by an increase in EtCO 2 . Only patients with a high O 2 ER (i.e., low ScvO 2 values) display an increase in EtCO 2 . Thus, EtCO 2 changes during fluid challenge predict changes in O 2 ER (i.e., ScVO 2 ) in response to an increase in DO 2 . EtCO 2 may be a useful noninvasive indicator of changes in systemic oxygen supply dependency in operative patients when fixed ventilation is maintained.
